Neutrophil CD64: diagnostic accuracy and prognostic value in patients presenting to the emergency department.
The purpose of this study was to evaluate the diagnostic accuracy and prognostic value of neutrophil CD64 expression for bacterial infection in febrile adult patients presenting to our hospital emergency department. We prospectively included 132 patients with fever ≥ 38ºC (≥ 100.4ºF) during the last 24 hours and we measured CD64 expression on neutrophils the day after admission at the emergency department. We followed the patients until full recovery or death. There were 115 (87%) patients with bacterial infection and 108 (94%) of them survived. There were 17 (13%) patients without bacterial infection and 12 (71%) of them survived. Patients with bacterial infection and patients who survived showed a CD64 index higher when compared with patients without bacterial infection and patients who died, respectively (3.7 ± 3.2 vs. 2.5 ± 2.3; p = 0.03; and 3.7 ± 3.1 vs. 1.7 ± 0.6; p = 0.002; Mann-Whitney U test). The receiver operating characteristic (ROC) curve analysis for detecting bacterial infection and predicting survival with the CD64 index showed an area under curve (AUC) of 0.66 (95% CI, 0.52-0.8; p = 0.03) and 0.71 (95% CI, 0.57-0.85; p = 0.01), respectively. Diagnostic accuracy and prognostic value of CD64 expression was good in adult patients with fever.
Haematology Service, University Hospital Joan XXIII, IISPV, Rovira and Virgili University, Tarragona, Spain. jcid@clinic.ub.es
J
J
Cid
G
G
García-Pardo
R
R
Aguinaco
R
R
Sánchez
A
A
Llorente
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001424:Bacterial Infections / Q000175:diagnosis* / Q000401:mortality; D004632:Emergency Medical Services / Q000379:methods*; D005260:Female; D005335:Fever of Unknown Origin / Q000175:diagnosis* / Q000401:mortality; D006761:Hospitals; D006801:Humans; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000737:chemistry*; D011379:Prognosis; D011446:Prospective Studies; D012372:ROC Curve; D017452:Receptors, IgG / Q000032:analysis*; D055815:Young Adult
D017452:Receptors, IgG
Clin Chem. 2003 Jan;49(1):7-18
12507954
CMAJ. 2006 Feb 14;174(4):469-76
16477057
Cytokine. 2006 Dec;36(5-6):283-90
17368039
Crit Care Med. 2003 Apr;31(4):1250-6
12682500
BMJ. 2008 May 17;336(7653):1106-10
18483053
Clin Chem Lab Med. 2009;47(8):903-16
19642859
Am J Gastroenterol. 2009 Jan;104(1):102-9
19098857
Clin Exp Immunol. 2008 Oct;154(1):87-97
18727624
Clin Infect Dis. 2004 Jul 15;39(2):206-17
15307030
Clin Chem. 2003 Jan;49(1):1-6
12507953
J Clin Epidemiol. 1994 Nov;47(11):1245-51
7722560
Blood. 1997 Oct 15;90(8):3187-94
9376602
BMJ. 2007 Oct 27;335(7625):879-83
17962288
Thromb Res. 2008;121(4):499-507
17597188
J Rheumatol. 2006 Dec;33(12):2416-24
17080517
J Infect. 2010 May;60(5):313-9
20206205
Intensive Care Med. 2009 Nov;35(11):1950-8
19756501
Lab Hematol. 2003;9(3):117-24
14521317
Scand J Infect Dis. 2010 Apr;42(4):299-305
20085423
Curr Opin Pediatr. 2006 Apr;18(2):125-31
16601490
J Immunol Methods. 2007 Dec 1;328(1-2):189-200
17905303
J Clin Microbiol. 2009 Dec;47(12):3914-9
19846647
J Bone Joint Surg Br. 2009 Sep;91(9):1237-42
19721054
Bone Marrow Transplant. 2003 Jun;31(12):1137-42
12796793
Expert Rev Mol Diagn. 2005 Mar;5(2):193-207
15833049
N Engl J Med. 2003 Apr 17;348(16):1546-54
12700374
Am J Hematol. 2010 May;85(5):380-3
20425801
Evid Based Med. 2008 Dec;13(6):162-3
19043023
Crit Care Med. 2005 Jul;33(7):1538-48
16003060
JAMA. 1999 Sep 15;282(11):1061-6
10493205